Skip to main content

Advertisement

Log in

Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The aim of our prospective case-control study was to evaluate long-term effects of GH replacement therapy on erythrocytes parameters, leukocytes, and platelets numbers in a large cohort of children with isolated GH deficiency (GHD). Hemoglobin (Hb) concentration, hematocrit (Hct), mean corpuscular volume, mean corpuscular hemoglobin, red cell distribution width, number of erythrocytes, leukocytes, neutrophils, lymphocytes, monocytes and platelets, ferritin, and C-reactive protein were evaluated in 85 children with isolated GHD (10.20 ± 3.50 years) before and annually during the first 5 years of GH replacement therapy and in 85 healthy children age and sex comparable to patients during 5 years of follow-up. Compared with controls, GHD children at study entry showed lower Hb (−1.18 ± 0.87 vs. −0.40 ± 0.90 SDS, p < 0.0001), red cells number (−0.24 ± 0.81 vs. 0.25 ± 1.14 SDS, p < 0.0001), and Hct (−1.18 ± 0.86 vs. −0.68 ± 0.99 SDS, p < 0.0001). Twelve GHD patients (14 %) showed a normocytic anemia. GH therapy was associated with a significant increase in Hb, Hct, and red cells number which became all comparable to controls within the first 2 years of treatment. Moreover, hemoglobin levels normalized in all anemic GHD patients after 5 years of therapy. No difference between patients and controls was found in leukocytes and platelets numbers neither at baseline nor during the study. GHD in childhood is associated with an impairment of erythropoiesis which causes a normocytic anemia in a considerable percentage of patients. GH replacement therapy exerts a beneficial effect leading to a significant increase of erythrocytes parameters and recovery from anemia. Neither GHD nor GH replacement treatment exerts effects on leukocytes or platelets numbers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. N. Møller, J.O. Jørgensen, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009)

    Article  PubMed  Google Scholar 

  2. J.L. Bresson, S. Jeay, M.C. Gagnerault, C. Kayser, N. Beressi, Z. Wu, S. Kinet, M. Dardenne, M.C. Postel-Vinay, Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein. Endocrinology 140, 3203–3209 (1999)

    CAS  PubMed  Google Scholar 

  3. M.B. Hanley, L.A. Napolitano, J.M. McCune, Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells 23, 1170–1179 (2005)

    Article  CAS  PubMed  Google Scholar 

  4. D.W. Golde, N. Bersch, C.H. Li, Growth hormone: species-specific stimulation of erythropoiesis in vitro. Science 196, 1112–1113 (1977)

    Article  CAS  PubMed  Google Scholar 

  5. W.J. Murphy, S.K. Durum, M.R. Anver, D.L. Longo, Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J. Immunol. 148, 3799–3805 (1992)

    CAS  PubMed  Google Scholar 

  6. A. Kurtz, J. Zapf, K.U. Eckardt, G. Clemons, E.R. Froesch, C. Bauer, Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc. Natl. Acad. Sci. U. S. A. 85, 7825–7829 (1988)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. G. Valerio, S. Di Maio, M. Salerno, A. Argenziano, R. Badolato, A. Tenore, Assessment of red blood cell indices in growth-hormone-treated children. Horm. Res. 47, 62–66 (1997)

    Article  CAS  PubMed  Google Scholar 

  8. M. Sohmiya, Y. Kato, Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency. Clin. Endocrinol. (Oxf.) 55, 749–754 (2001)

    Article  CAS  Google Scholar 

  9. E.A. Eugster, M. Fisch, E.C. Walvoord, L.A. DiMeglio, O.H. Pescovitz, Low hemoglobin levels in children with in idiopathic growth hormone deficiency. Endocrine 18, 135–136 (2002)

    Article  CAS  PubMed  Google Scholar 

  10. S. Bergamaschi, C. Giavoli, E. Ferrante, A. Lania, R. Rusconi, A. Spada, P. Beck-Peccoz, Growth hormone replacement therapy in growth hormone deficient children and adults: effects on hemochrome. J. Endocrinol. Invest. 29, 399–404 (2006)

    Article  CAS  PubMed  Google Scholar 

  11. R. Miniero, F. Altomare, M. Rubino, P. Matarazzo, C. Montanari, A. Petri, G. Raiola, G. Bona, Effect of recombinant human growth hormone (rhGH) on hemoglobin concentration in children with idiopathic growth hormone deficiency-related anemia. J. Pediatr. Hematol. Oncol. 34, 407–411 (2012)

    Article  CAS  PubMed  Google Scholar 

  12. E.R. Christ, M.H. Cummings, N.B. Westwood, B.M. Sawyer, T.C. Pearson, P.H. Sönksen, D.L. Russell-Jones, The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 82, 2985–2990 (1997)

    CAS  PubMed  Google Scholar 

  13. M.P. Kawa, I. Stecewicz, K. Piecyk, E. Pius-Sadowska, E. Paczkowska, D. Rogińska, A. Sobuś, K. Łuczkowska, E. Gawrych, E. Petriczko, M. Walczak, B. Machaliński, Effects of growth hormone therapeutic supplementation on hematopoietic stem/progenitor cells in children with growth hormone deficiency: focus on proliferation and differentiation capabilities. Endocrine 50, 162–175 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. H. Kotzmann, M. Riedl, M. Clodi, U. Barnas, A. Kaider, P. Höcker, A. Luger, The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur. J. Clin. Invest. 26, 1175–1181 (1996)

    Article  CAS  PubMed  Google Scholar 

  15. W. Savino, M. Dardenne, Pleiotropic modulation of thymic functions by growth hormone: from physiology to therapy. Curr. Opin. Pharmacol. 10, 434–442 (2010)

    Article  CAS  PubMed  Google Scholar 

  16. M. Sohmiya, I. Kanazawa, Y. Kato, Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency. Eur. J. Endocrinol. 152, 211–215 (2005)

    Article  CAS  PubMed  Google Scholar 

  17. S.M. Ten Have, A.J. van der Lely, S.W. Lamberts, Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy. Clin. Endocrinol. (Oxf.) 47, 565–570 (1997)

    Article  Google Scholar 

  18. G.L. Spadoni, P. Rossi, W. Ragno, E. Galli, S. Cianfarani, C. Galasso, B. Boscherini, Immune function in growth hormone-deficient children treated with biosynthetic growth hormone. Acta Paediatr. Scand. 80, 75–79 (1991)

    Article  CAS  PubMed  Google Scholar 

  19. R. Manfredi, F. Tumietto, L. Azzaroli, A. Zucchini, F. Chiodo, G. Manfredi, Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH. J. Pediatr. Endocrinol. 7, 245–251 (1994)

    Article  CAS  PubMed  Google Scholar 

  20. C. Meazza, I. Bonomelli, S. Pagani, P. Travaglino, K. Laarej, F. Cantoni, M. Bozzola, Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte-colony stimulating factor in short children. J. Pediatr. Endocrinol. Metab. 22, 837–843 (2009)

    Article  CAS  PubMed  Google Scholar 

  21. Y. Xu, S. Wang, M. Shen, Z. Zhang, S. Chen, F. Chen, M. Chen, D. Zeng, A. Wang, J. Zhao, T. Cheng, Y. Su, J. Wang, hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesis. Blood 123, 2250–2260 (2014)

    Article  CAS  PubMed  Google Scholar 

  22. Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J. Clin. Endocrinol. Metab. 85, 3990–3993 (2000)

    Google Scholar 

  23. E. Cacciari, S. Milani, A. Balsamo, E. Spada, G. Bona, L. Cavallo, F. Cerutti, L. Gargantini, N. Greggio, G. Tonini, A. Cicognani, Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J. Endocrinol. Invest. 29, 581–593 (2006)

    Article  CAS  PubMed  Google Scholar 

  24. S.H. Orkin, D.E. Fisher, A.T. Look, S.E. Lux, D. Ginsburg, D.G. Nathan, Nathan and Oski’s hematology of infancy and childhood (Saunders, Philadelphia, 2009)

    Google Scholar 

  25. O. Livnah, E.A. Stura, D.L. Johnson, S.A. Middleton, L.S. Mulcahy, N.C. Wrighton, W.J. Dower, L.K. Jolliffe, I.A. Wilson, Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 273, 464–471 (1996)

    Article  CAS  PubMed  Google Scholar 

  26. D. Capalbo, G. Mattace Raso, A. Esposito, R. Di Mase, F. Barbieri, R. Meli, D. Bruzzese, M. Salerno, Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study. Clin. Endocrinol. (Oxf.) 80, 856–862 (2014)

    Article  CAS  Google Scholar 

  27. I.M. van der Sluis, A.M. Boot, W.C. Hop, Y.B. De Rijke, E.P. Krenning, S.M. de Muinck Keizer-Schrama, Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study. Horm. Res. 58, 207–214 (2002)

    Article  PubMed  Google Scholar 

  28. D.A. Weigent, Lymphocyte GH-axis hormones in immunity. Cell. Immunol. 285, 118–132 (2013)

    Article  CAS  PubMed  Google Scholar 

  29. G. Morrhaye, H. Kermani, J.J. Legros, F. Baron, Y. Beguin, M. Moutschen, R. Cheynier, H.J. Martens, V. Geenen, Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE (2009). doi:10.1371/journal.pone.0005668

    PubMed  PubMed Central  Google Scholar 

  30. O. Serri, P. St-Jacques, M. Sartippour, G. Renier, Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. J. Clin. Endocrinol. Metab. 84, 58–63 (1999)

    CAS  PubMed  Google Scholar 

  31. S.B. Sneppen, H. Mersebach, H. Ullum, U. Feldt-Rasmussen, Immune function during GH treatment in GH-deficient adults: an 18-month randomized, placebo-controlled, double-blinded trial. Clin. Endocrinol. (Oxf.) 57, 787–792 (2002)

    Article  CAS  Google Scholar 

  32. I. Vigliano, A. Fusco, L. Palamaro, G. Aloj, E. Cirillo, M.C. Salerno, C. Pignata, γ Chain transducing element: a shared pathway between endocrine and immune system. Cell. Immunol. 269, 10–15 (2011)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariacarolina Salerno.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esposito, A., Capalbo, D., De Martino, L. et al. Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency. Endocrine 53, 192–198 (2016). https://doi.org/10.1007/s12020-015-0781-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0781-9

Keywords

Navigation